Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01167218 · ClinicalTrials.gov registry record
Study to Assess Platelet Dysfunction With Verify Now Assay
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 79
- Enrollment target
NCT01167218: Completed study, sponsored by NYU Langone Health.
NCT01167218 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 79 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01167218 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 79 participants
- Enrollment target
Study Summary
The purpose of this study is to conduct a Verify now assay to detect platelet aggregation defects in patients with Myelodysplastic syndrome(MDS), immune thrombocytopenia purpura (ITP) and myeloproliferative disorders (MPD).
Primary Outcome
to assess platelet aggregation defects
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2009-12 |
| Est. Completion | 2012-02 |
What the finished NCT01167218 record still lists
NCT01167218 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 79 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01167218 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01167218 about?
NCT01167218 is a clinical study titled "Study to Assess Platelet Dysfunction With Verify Now Assay". The purpose of this study is to conduct a Verify now assay to detect platelet aggregation defects in patients with Myelodysplastic syndrome(MDS), immune thrombocytopenia purpura (ITP) and myeloproliferative disorders (MPD).
What is the current status of trial NCT01167218?
This trial is currently completed. The enrollment target is 79 participants. The study started on 2009-12. Estimated completion is 2012-02.
Who is sponsoring clinical trial NCT01167218?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05798897 · 79 participants · Phase 1
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- NCT06042439 · 79 participants · NA
AM vs PM Exercise Training
- NCT06223555 · 79 participants · NA
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia